PHARMAC - Latest News [Page 1]

Pharmac Negotiates Deal For Molnupiravir To Treat COVID-19

Monday, 11 October 2021, 6:17 am | PHARMAC

Pharmac has negotiated an agreement with supplier Merck Sharp & Dohme (MSD) to purchase the antiviral molnupiravir. It will be used to treat New Zealanders with mild to moderate COVID-19 symptoms, subject to the treatment gaining regulatory approval ... More >>

Pharmac funds new treatment for rheumatoid arthritis

Thursday, 16 September 2021, 2:47 pm | PHARMAC

Pharmac has funded upadacitinib tablets as an alternative treatment for New Zealanders with severe rheumatoid arthritis, who are impacted by the tocilizumab stock shortage More >>

Pharmac funds tocilizumab to treat cases of COVID-19

Thursday, 16 September 2021, 2:46 pm | PHARMAC

Pharmac is widening funded access to tocilizumab, an immunosuppressive drug used mainly to treat arthritis, to treat moderate to severe cases of COVID-19, subject to access criteria from 1 October 2021. This means prescribers will not have to make ... More >>

Limiting the impact on Kiwis as API leaves the NZ market

Tuesday, 14 September 2021, 2:28 pm | PHARMAC

Pharmac is working hard to limit the impact on over 1 million Kiwis who currently take funded API Consumer Brands (API) medicines, following their announcement that they are leaving the New Zealand market. API announced in July this year they are ... More >>

Pharmac confirms primidone to stay the same

Tuesday, 7 September 2021, 11:10 am | PHARMAC

Pharmac is pleased to confirm that there will be no change in primidone tablets, a treatment used for the management of seizures and epilepsy. In June Pharmac put out a consultation on the supply of an alternative brand of primidone . “We did ... More >>

New Zealand’s tocilizumab supply to be paused

Monday, 6 September 2021, 1:08 pm | PHARMAC

Pharmac has today announced that Roche, the global pharmaceutical company which provides tocilizumab, will not provide New Zealand with product for the next three months, due to massive demand worldwide. “Tocilizumab (Actemra) is an anti-inflammatory ... More >>

Pharmac seeks feedback on a biosimilar brand of adalimumab

Thursday, 26 August 2021, 3:42 pm | PHARMAC

Pharmac is considering awarding principal supply to a biosimilar brand of adalimumab (Amgevita) from 1 February 2022. More >>

Pharmac Commits To Being More Transparent

Wednesday, 28 July 2021, 11:03 am | PHARMAC

For the first time, Pharmac is sharing its priority lists for all funding applications for medicines it has assessed but not yet funded. Pharmac’s Chief Executive Sarah Fitt explains, “Until now, we have not shared what applications were on which list, ... More >>

Pharmac Ensuring Supply Of Prednisolone To Treat Children With RSV

Monday, 19 July 2021, 11:44 am | PHARMAC

Pharmac is working hard to ensure ongoing supply of a critical medicine used to treat RSV, following the outbreak of the respiratory virus in our communities. “Prednisolone is a steroid medication used to treat multiple conditions, including RSV,” says ... More >>

Application For Cystic Fibrosis Medicine Received By Pharmac

Friday, 9 July 2021, 9:59 am | PHARMAC

Pharmac is starting its funding assessment process for a new cystic fibrosis medication after receiving an application from pharmaceutical company Vertex. Vertex has applied for its triple combination modulator therapy medicine to be funded for people aged ... More >>

PHARMAC Is Seeking Views On Declining Funding Applications

Wednesday, 30 June 2021, 9:04 am | PHARMAC

PHARMAC is considering declining 97 inactive medicine funding applications. Previously inactive applications have remained on PHARMAC’s books, despite being unlikely to be approved for funding. This has caused confusion as to if they will be funded ... More >>

PHARMAC Seeking Views On New Brand Of Primidone

Tuesday, 22 June 2021, 4:00 pm | PHARMAC

PHARMAC has reached a provisional agreement with medicine supplier Teva to fund a new brand of primidone which is most commonly used to treat and prevent seizures in people with epilepsy. The current supplier of primidone, Apotex, is discontinuing ... More >>

Free Meningococcal B Vaccine For People Most At Risk

Friday, 18 June 2021, 11:43 am | PHARMAC

Around 1,500 people who are at higher risk of contracting meningococcal disease will soon be able to get the meningococcal B vaccine for free. Meningococcal disease can lead to serious illnesses including meningitis (inflammation of your brain membranes) ... More >>

PHARMAC To Work With Others To Improve Communication

Friday, 21 May 2021, 5:06 am | PHARMAC

PHARMAC accepts the coroner’s comments that not all information about the brand change reached patients. “We offer our deepest condolences to the families and friends of Ricky Blackler, Reuben Brown, Krystle Loye, Andre Maddock, William Oliver, ... More >>

Cystic Fibrosis Medicine Applications To Be Considered By PHARMAC And Medsafe In Parallel

Thursday, 1 April 2021, 2:32 pm | PHARMAC

PHARMAC met this week with Vertex, a supplier of cystic fibrosis medicines, and with Medsafe, the safety and quality regulator for medicines. The meeting was an opportunity to discuss Vertex’s modulator therapy and the process for this type ... More >>

PHARMAC Widens Access To Funded Treatments For Multiple Sclerosis

Friday, 12 February 2021, 10:00 am | PHARMAC

PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March. 1800 people with multiple sclerosis will be able to stay on their treatment for longer, and some who had stopped funded treatment may now ... More >>

Teen Thriving On PHARMAC Funded Medicine

Tuesday, 9 February 2021, 10:42 am | PHARMAC

14-year-old Bruno Cettina is living his best life thanks to a medicine funded by PHARMAC. According to his proud mum, he is a keen sportsman, a musician, an above average student at school and is tackling life with vigour. Bruno is also one of ... More >>

PHARMAC To Fund New Diabetes Medicines With Amended Special Authority Criteria

Monday, 21 December 2020, 12:10 pm | PHARMAC

PHARMAC has approved funding for two new medicines with substantial health benefits for around 53,000 New Zealanders with type 2 diabetes. Read this media release in Te Reo Māori People with high-risk type 2 diabetes, who meet the funding criteria, ... More >>

Dr Crawshaw takes over as PHARMAC’s medical director

Friday, 27 November 2020, 9:59 am | PHARMAC

PHARMAC is pleased to announce that Dr Shirley Crawshaw, seven months after she was appointed, has arrived in New Zealand and commenced her role in the senior leadership team of PHARMAC as the medical director. More >>

PHARMAC Media Release On A New Funding Decision

Wednesday, 11 November 2020, 9:12 am | PHARMAC

From 1 December 2020 a new medicine will be funded by PHARMAC which will help some people with severe haemophilia A. Emicizumab (branded as Hemlibra and supplied by Roche) is a new cutting-edge preventative treatment for people with severe haemophilia ... More >>